Other Assets, Current in USD of ARROWHEAD PHARMACEUTICALS, INC. from Q3 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly Other Assets, Current history and change rate from Q3 2013 to Q3 2025.
  • Arrowhead Pharmaceuticals, Inc. Other Assets, Current for the quarter ending 30 Sep 2025 was $13.5M, a 172% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Change (%)

ARROWHEAD PHARMACEUTICALS, INC. Quarterly Other Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $13.5M +$8.54M +172% 30 Sep 2025 10-K 25 Nov 2025
Q2 2025 $13.2M +$8.98M +215% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $11.7M +$4.16M +55.4% 31 Mar 2025 10-Q 12 May 2025
Q4 2024 $5.74M -$1.37M -19.3% 31 Dec 2024 10-Q 10 Feb 2025
Q3 2024 $4.97M +$940K +23.3% 30 Sep 2024 10-K 25 Nov 2025
Q2 2024 $4.18M -$2.98M -41.6% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $7.51M -$6.92M -48% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $7.1M -$18.1M -71.8% 31 Dec 2023 10-Q 06 Feb 2024
Q3 2023 $4.03M -$16.2M -80% 30 Sep 2023 10-K 26 Nov 2024
Q2 2023 $7.16M -$1.73M -19.5% 30 Jun 2023 10-Q 07 Aug 2023
Q1 2023 $14.4M +$6.64M +85.2% 31 Mar 2023 10-Q 02 May 2023
Q4 2022 $25.2M +$22.4M +801% 31 Dec 2022 10-Q 06 Feb 2023
Q3 2022 $20.2M +$18M +822% 30 Sep 2022 10-K 29 Nov 2023
Q2 2022 $8.89M +$7.2M +424% 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 $7.8M +$5.95M +323% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $2.8M +$477K +20.6% 31 Dec 2021 10-Q 02 Feb 2022
Q3 2021 $2.19M +$409K +23% 30 Sep 2021 10-K 28 Nov 2022
Q2 2021 $1.7M -$716K -29.7% 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $1.85M -$691K -27.3% 31 Mar 2021 10-Q 04 May 2021
Q4 2020 $2.32M +$784K +51.1% 31 Dec 2020 10-Q 04 Feb 2021
Q3 2020 $1.78M -$781K -30.5% 30 Sep 2020 10-K 22 Nov 2021
Q2 2020 $2.41M +$920K +61.6% 30 Jun 2020 10-Q 05 Aug 2020
Q1 2020 $2.54M +$946K +59.5% 31 Mar 2020 10-Q 07 May 2020
Q4 2019 $1.53M +$1.06M +221% 31 Dec 2019 10-Q 05 Feb 2020
Q3 2019 $2.56M +$1.92M +300% 30 Sep 2019 10-K 23 Nov 2020
Q2 2019 $1.49M +$1.21M +435% 30 Jun 2019 10-Q 05 Aug 2019
Q1 2019 $1.59M +$1.23M +344% 31 Mar 2019 10-Q 08 May 2019
Q4 2018 $478K -$1.13M -70.2% 31 Dec 2018 10-Q 07 Feb 2019
Q3 2018 $640K -$720K -52.9% 30 Sep 2018 10-K 25 Nov 2019
Q2 2018 $279K -$617K -68.9% 30 Jun 2018 10-Q 07 Aug 2018
Q1 2018 $358K -$1.39M -79.5% 31 Mar 2018 10-Q 08 May 2018
Q4 2017 $1.6M -$1.89M -54.1% 31 Dec 2017 10-Q 09 Feb 2018
Q3 2017 $1.36M -$2.41M -63.9% 30 Sep 2017 10-K 11 Dec 2018
Q2 2017 $896K -$611K -40.6% 30 Jun 2017 10-Q 03 Aug 2017
Q1 2017 $1.75M +$838K +92.2% 31 Mar 2017 10-Q 03 May 2017
Q4 2016 $3.5M +$1.59M +83.6% 31 Dec 2016 10-Q 06 Feb 2017
Q3 2016 $3.77M +$2.95M +358% 30 Sep 2016 10-K 12 Dec 2017
Q2 2016 $1.51M +$853K +130% 30 Jun 2016 10-Q 09 Aug 2016
Q1 2016 $910K +$582K +178% 31 Mar 2016 10-Q 10 May 2016
Q4 2015 $1.9M +$1.84M +2930% 31 Dec 2015 10-Q 09 Feb 2016
Q3 2015 $824K +$775K +1598% 30 Sep 2015 10-K 14 Dec 2016
Q2 2015 $655K +$116K +21.6% 30 Jun 2015 10-Q 04 Aug 2015
Q1 2015 $327K -$306K -48.3% 31 Mar 2015 10-Q 11 May 2015
Q4 2014 $62.8K 31 Dec 2014 10-Q 09 Feb 2015
Q3 2014 $48.5K -$43.2K -47.1% 30 Sep 2014 10-K 14 Dec 2015
Q2 2014 $539K 30 Jun 2014 10-Q 12 Aug 2014
Q1 2014 $634K 31 Mar 2014 10-Q 06 May 2014
Q3 2013 $91.7K 30 Sep 2013 10-K 25 Nov 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.